Affinage · Plasmodium

PfP0

PF3D7_1130200 · 60S ribosomal protein P0

Annotated
2026-09-08
12 papers in source corpus 8 papers cited in narrative 8 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PfP0 (PF3D7_1130200) is the P0/uL10 anchor protein of the Plasmodium falciparum ribosomal stalk, and it additionally functions as a surface-exposed, invasion-associated antigen on merozoites and sexual stages (PMID:10779592, PMID:25450178). As the stalk anchor, PfP0 nucleates a pentameric PfP0–(PfP1–PfP2)₂ complex through a distinctive one-step assembly that requires all three P-proteins simultaneously, without a stable PfP1–PfP2 heterodimeric intermediate, with PfP2 homo-oligomers arising as an off-pathway product (PMID:25450178). PfP0 functionally complements yeast P0-null mutants and can even rescue a strain lacking both yeast P1 proteins, supporting ribosome polymerizing activity without P1; it does not bind yeast P1 and shows sordarin sensitivity like fungal P0, marking its stalk interactions as divergent (PMID:16099608). Independently of its ribosomal role, PfP0 is displayed on the merozoite surface, where its N-terminal, C-terminal, and P domains are targeted by antibodies that block red blood cell re-invasion in vitro and confer protection against lethal parasite challenge in vivo (PMID:10779592, PMID:10858250, PMID:15322057). Synthetic peptides spanning PfP0 bind human RBCs and engage a protease-sensitive ~58-kDa RBC membrane protein, and these binding peptides inhibit merozoite invasion, linking PfP0 surface display to the invasion machinery (PMID:19768630).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2000 Medium

    Establishing that a nominally ribosomal protein is displayed on the parasite surface and is functionally required for invasion reframed PfP0 as a dual-function antigen accessible to host immunity.

    Evidence Domain-specific IgG (anti-PfP0N, anti-PfP0C) in vitro invasion-inhibition assays plus surface immunofluorescence on merozoites and sexual stages

    PMID:10779592

    Open questions at the time
    • Mechanism by which a ribosomal protein reaches the merozoite surface is unresolved
    • Molecular target of the inhibitory antibodies on the parasite surface not identified in this study
  2. 2000 Medium

    Passive transfer testing whether anti-PfP0 antibodies protect in vivo established PfP0 as a candidate invasion-blocking vaccine target with cross-species efficacy.

    Evidence Passive transfer of anti-PfP0N/PfP0C IgG into mice challenged with lethal P. yoelii 17XL, with parasitemia and survival readouts

    PMID:10858250

    Open questions at the time
    • Cross-species protection implies a conserved epitope but the shared target was not defined
    • ~50% survival indicates incomplete protection; effector requirements unknown
  3. 2001 Medium

    Testing whether naturally occurring human autoantibodies cross-react with PfP0 showed anti-PfP0 antibodies alone drive parasite growth inhibition, confirming PfP0 as the mechanistically responsible antigen.

    Evidence In vitro growth inhibition with SLE-patient IgG followed by anti-PfP0 antibody depletion to demonstrate loss of activity

    PMID:11683400

    Open questions at the time
    • Whether autoimmune cross-reactivity has any role in natural malaria immunity is not addressed
    • Epitope on the PfP0 C-terminal domain not mapped at residue level
  4. 2004 Medium

    Narrowing the protective epitope to the P domain identified a discrete functionally critical region for invasion and vaccination.

    Evidence P-domain-specific monoclonal antibody invasion-inhibition assays and in vivo P-domain peptide vaccination/challenge in mice

    PMID:15322057

    Open questions at the time
    • How the P domain contributes mechanistically to invasion is unknown
    • P-domain function here is not linked to its ribosomal-stalk role
  5. 2004 Low

    A yeast two-hybrid and Co-IP screen sought PfP0 interaction partners, extending its interactome beyond ribosomal proteins to a hypothetical membrane protein.

    Evidence Yeast two-hybrid screen, anti-P0 co-immunoprecipitation, and deletion mapping of the ScP0 interaction domain (aa 60–148)

    PMID:15286401

    Open questions at the time
    • Single Co-IP/two-hybrid without functional follow-up in P. falciparum
    • Interaction with the YFL034W membrane protein not validated in the parasite
    • Physiological relevance of the mapped domain to PfP0 function unknown
  6. 2005 High

    Cross-species genetic complementation defined PfP0 as a functional ribosomal stalk anchor with divergent P1 dependence, distinguishing its stalk biology from that of the host.

    Evidence Complementation of yeast P0-null and P1α/P1β-null mutants, yeast two-hybrid, in vitro ribosome polymerization assays, and sordarin sensitivity testing

    PMID:16099608

    Open questions at the time
    • Whether PfP0 requires PfP1 in the native P. falciparum ribosome not tested here
    • Structural basis of the lack of ScP1 binding not resolved
  7. 2009 Medium

    Fine peptide mapping localized RBC-binding activity within PfP0 and identified the erythrocyte receptor it engages, connecting surface display to a defined host ligand.

    Evidence Synthetic 20-mer peptide RBC-binding assays, enzyme treatment, cross-linking to a ~58-kDa RBC membrane protein, and in vitro invasion inhibition

    PMID:19768630

    Open questions at the time
    • Identity of the ~58-kDa RBC membrane protein not molecularly determined
    • Whether full-length surface PfP0 engages this receptor during native invasion untested
  8. 2014 High

    Reconstitution of stalk assembly resolved how PfP0 organizes the pentameric complex, revealing a one-step, all-three-proteins assembly mode distinct from the stepwise dimer-loading model.

    Evidence Tricistronic bacterial expression of the P-stalk, mass spectrometry, bacterial two-hybrid, and biophysical characterization

    PMID:25450178

    Open questions at the time
    • Atomic structure of the PfP0–(PfP1–PfP2)₂ complex not determined
    • Physiological factors controlling assembly in the parasite not identified

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PfP0 is trafficked from the ribosome to the merozoite surface and how its ribosomal anchor function relates mechanistically to its RBC-invasion role remain unresolved.
  • No mechanism links stalk-anchor function to surface display
  • The ~58-kDa RBC receptor remains molecularly unidentified
  • No native-parasite genetic test of PfP0's role in invasion

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
PFP1 (RIBOSOMAL STALK P1 PROTEIN) [#6]PFP2 (RIBOSOMAL STALK P2 PROTEIN) [#6]YFL034W HYPOTHETICAL MEMBRANE PROTEIN (YEAST TWO-HYBRID/CO-IP) [#3]~58-KDA PROTEASE-SENSITIVE RBC MEMBRANE PROTEIN (RECEPTOR) [#5]
Complex memberships
Pentameric ribosomal stalk complex PfP0–(PfP1–PfP2)₂ [#6]

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 IgG antibodies raised against both the N-terminal domain (PfP0N, aa 17–61) and C-terminal domain (PfP0C, aa 61–316) of PfP0 specifically inhibited re-invasion of red blood cells by P. falciparum merozoites in vitro in a concentration-dependent manner, with no significant effect on intraerythrocytic stages; immunofluorescence assays showed surface reactivity of merozoites and sexual stages to both anti-PfP0N and anti-PfP0C antibodies, indicating surface localization of PfP0. In vitro P. falciparum growth inhibition assay with purified IgG fractions; immunofluorescence assay on merozoites and sexual stages Molecular and biochemical parasitology Medium 10779592
2000 Passive transfer of purified IgG from rabbits and mice immunized against PfP0N or PfP0C into mice challenged with the lethal P. yoelii 17XL strain resulted in significantly lower parasitemia and ~50% survival, demonstrating cross-species protection and establishing PfP0 as a target for invasion-blocking antibodies. Passive immunization/transfer experiment in mice with purified anti-PfP0 IgG followed by lethal P. yoelii challenge Infection and immunity Medium 10858250
2004 Monoclonal antibodies specific for the P domain of PfP0 blocked invasion of RBCs by P. falciparum, and vaccination with a P-domain peptide protected mice against malaria parasite challenge, further defining the P domain as functionally critical for RBC invasion. In vitro RBC invasion inhibition assay with monoclonal antibodies; in vivo vaccination/challenge experiment in mice Infection and immunity Medium 15322057
2004 A yeast two-hybrid screen identified interacting partners of PfP0, including ribosomal proteins, nucleotide-binding proteins, and a hypothetical integral membrane protein encoded by yeast YFL034W; the YFL034W protein was co-immunoprecipitated with anti-P0 antibodies together with both PfP0 and ScP0, and the interacting domain of ScP0 was mapped to amino acids 60–148 by deletion constructs. Yeast two-hybrid screen; co-immunoprecipitation with anti-P0 antibodies; deletion mapping of interaction domain Journal of biosciences Low 15286401
2005 PfP0 functionally complemented the conditional P0-null mutant of Saccharomyces cerevisiae (W303dGP0), and uniquely also rescued the D67dGP0 strain null for both ScP1α and ScP1β, indicating PfP0 can support ribosomal function without P1 proteins; yeast two-hybrid analysis confirmed lack of binding of ScP1 to PfP0; ribosomes from yeast expressing PfP0 lacked ScP1 and showed ~40–45% of normal polymerizing activity; PfP0 showed similar sensitivity to the inhibitor sordarin as fungal P0, indicating functional closer relationship to fungal than mammalian P0. Functional complementation of yeast P0-null mutants; yeast two-hybrid; in vitro ribosome polymerization assay; sordarin inhibitor sensitivity assay Gene High 16099608
2009 Fine mapping with synthetic 20-mer peptides spanning PfP0 identified four high-activity binding peptides (HABPs 33898, 33900, 33901, 33906) that bind human RBCs; HABPs 33898 and 33906 bind a protease-sensitive ~58-kDa RBC membrane protein identified by cross-linking, both peptides have high α-helical content, and both inhibit P. falciparum merozoite invasion of RBCs in vitro by up to 91%. Receptor-ligand binding assays with synthetic peptides on human RBCs; enzyme-treatment of RBCs; cross-linking assays; in vitro invasion inhibition assay Journal of molecular medicine Medium 19768630
2014 In vivo assembly of the P. falciparum ribosomal stalk requires all three P-proteins (PfP0/uL10, PfP1, PfP2) simultaneously; no stable PfP1–PfP2 heterodimeric intermediate forms, and the pentameric PfP0–(PfP1–PfP2)₂ complex is the most stable architecture; PfP2 homo-oligomers represent an off-pathway product. The unique one-step assembly mode was established by mass spectrometry, bacterial two-hybrid assay, and biophysical analyses. Tricistronic in vivo bacterial expression of P-stalk components; mass spectrometry; bacterial two-hybrid assay; biophysical characterization Biochimica et biophysica acta High 25450178
2001 IgG purified from SLE patient serum cross-reactive with the carboxy-terminal domain of PfP0 inhibited growth of P. falciparum in vitro; depletion of anti-PfP0 antibodies from this IgG preparation abolished growth inhibition, demonstrating that anti-PfP0 antibodies are responsible for the inhibitory activity. In vitro P. falciparum growth inhibition with purified IgG; antibody depletion experiment; Western blot Autoimmunity Medium 11683400

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2005 Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infection and immunity 75 15908375
2011 Human cord blood CD4+CD25hi regulatory T cells suppress prenatally acquired T cell responses to Plasmodium falciparum antigens. Journal of immunology (Baltimore, Md. : 1950) 51 21278348
2000 Antibodies against ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii. Infection and immunity 34 10858250
2004 The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasites. Infection and immunity 32 15322057
2000 Characterization of domains of the phosphoriboprotein P0 of Plasmodium falciparum. Molecular and biochemical parasitology 29 10779592
2005 Functional complementation of yeast ribosomal P0 protein with Plasmodium falciparum P0. Gene 20 16099608
1996 Cloning of a ribosomal phosphoprotein P0 gene homologue from Plasmodium falciparum. Molecular and biochemical parasitology 18 8943156
2001 Sera from lupus patients inhibit growth of P. falciparum in culture. Autoimmunity 8 11683400
2004 Identification of a hypothetical membrane protein interactor of ribosomal phosphoprotein P0. Journal of biosciences 6 15286401
2014 In vivo formation of Plasmodium falciparum ribosomal stalk - a unique mode of assembly without stable heterodimeric intermediates. Biochimica et biophysica acta 4 25450178
2012 Plasmodium riboprotein PfP0 induces a deviant humoral immune response in Balb/c mice. Journal of biomedicine & biotechnology 2 22315513
2009 Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells. Journal of molecular medicine (Berlin, Germany) 2 19768630